Skip to main content
ARTL
NASDAQ Life Sciences

Artelo Biosciences' Q1 Net Loss Widens to $3M, Dwarfing Its Market Cap

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$2.338
Mkt Cap
$2.195M
52W Low
$2.3
52W High
$85.8
52W Position info
1.7% above low
Off High info
97% below high
Rel. Volume
Market data snapshot near publication time

ARTL is trading near its 52-week low of $2.3 (1.7% above the low).

Summary

Artelo Biosciences reported a Q1 net loss of $3.0 million, widening from $2.4 million in the prior year, while R&D expenses fell to $0.8 million and G&A expenses increased to $1.9 million. This financial update follows the company's recent S-3 filing for a $75 million universal shelf registration on May 4th, and a prior 10-K (February 24th) that included a going concern warning. The Q1 net loss of $3.0 million is highly material, significantly exceeding the company's current market capitalization, which raises severe financial viability concerns despite management's statement about a "significant cash runway" from a recent capital raise. The decrease in R&D spending for a clinical-stage biotech could also signal a slowdown in pipeline development. Investors will be closely monitoring how the company plans to manage its cash burn and utilize its capital programs to fund operations, as financial stability is paramount for its clinical progress.

At the time of this announcement, ARTL was trading at $2.34 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.2M. The 52-week trading range was $2.30 to $85.80. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

ARTL - Latest Insights

ARTL
Oct 09, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.19
Real-time Price: $1.93 info
Change: -$1.26 (-39%) info
Market Cap: $1.046M info
ARTL
Sep 23, 2026, 1:46 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $7.84
Real-time Price: $1.93 info
Change: -$5.91 (-75%) info
Market Cap: $1.046M info
ARTL
Sep 16, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.02
Real-time Price: $1.93 info
Change: -$3.09 (-62%) info
Market Cap: $1.046M info
ARTL
Aug 27, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.658
Real-time Price: $1.93 info
Change: Reverse Stock Split info
Market Cap: $1.046M info
ARTL
Aug 27, 2026, 8:03 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.6899
Real-time Price: $1.93 info
Change: Reverse Stock Split info
Market Cap: $1.046M info